Search Results 1051-1060 of 15459 for alt

1. Metabolic dysfunction-Associated Fatty Liver Disease - Mayo Clinic

   FIB-4 score ≥ 2.67 (calculated from patient's age, AST, ALT, and platelet count); AST ≥ 30. Exclusion Criteria: Comorbidities that limit life expectancy to ...

2. A Study of ONC201 for Patients with H3 K27M-mutant and/or Midline High Grade Gliomas - Mayo Clinic

   AST (SGOT)/ALT (SGPT) ≤ 2 X ULN; ≤ 5 X ULN if there is liver involvement secondary to tumor;; Serum creatinine ≤ 1.5 X ULN (OR creatinine clearance ≥ 60 ...

3. Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors - Mayo Clinic

   Patients without liver metastases must have ALT and AST ≤ 2.5 × ULN; patients with liver metastases must have ALT and AST ≤ 5 × ULN;; Urine protein ≤ 1+ ...

4. A Study to Evaluate Trifluridine/Tipiracil in Combination with Irinotecan to Treat Biliary Tract Cancers - Mayo Clinic

   spartate transaminase (AST) or alanine transaminase (ALT) ≤ × ULN;; Creatinine ≤ 1.5 × ULN. Negative pregnancy test done ≤ days prior to registration, for ...

5. A Study of Response, Survival, Safety, and Tolerability of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer - Mayo Clinic

   Alkaline phosphatase (ALP), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) ≤ 3 x ULN (≤ 5 x ULN if participant has liver metastases) ...

6. Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

   Aspartate transaminase (AST) or alanine transaminase (ALT) ≤3 x ULN, unless considered due to organ leukemic involvement. Women of child-bearing potential ...

7. A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency - Mayo Clinic

   Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 3 × ULN;; Bilirubin ≤ 1.5 × ULN (< 2 x ULN if hyperbilirubinemia is due to Gilbert's ...

8. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

   Hepatic: Aspartate transaminase (AST) / Alanine transaminase (ALT) ≤ 2.5 x upper limit of normal (ULN) (if liver metastases are present, ≤ 5 x ULN); Total or ...

9. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Stage 3 Liver Fibrosis - Mayo Clinic

   ALT value > 5× the upper limit of normal (ULN) as defined by the central ... Evidence of significant worsening of ALT, AST or bilirubin during the ...

10. Adipose-Derived Mesenchymal Stem Cells (AMSCs) For Recurrent Glioblastoma - Mayo Clinic

    ALT, AST and alkaline phosphatase ≤ 3 times the upper limit of normal, and bilirubin ≤ 2.5 mg/dL;; Prothrombin time ≤1.5 times upper limit of normal;; INR ...